CoQ10 vs PQQ: Two Mitochondrial Supplements That Do Opposite Jobs

CoQ10 and PQQ are sold side by side, often in the same capsule, under the same heading of mitochondrial support. They do close to opposite jobs, and the evidence behind them is not remotely equal. One is a well-established cofactor with decades of clinical use; the other is an interesting molecule with a thin human record and an unusually good marketing story.

Two different jobs, not two brands of the same thing

CoQ10 works inside the mitochondria you already have. It is an essential electron carrier in the electron transport chain, shuttling electrons at Complex III — without it, oxidative phosphorylation does not run. It doubles as a potent lipid-soluble antioxidant protecting membranes from oxidative damage. It is maintenance and throughput.

PQQ is sold on the claim that it builds new mitochondria. The mechanism proposed is stimulation of mitochondrial biogenesis via PGC-1α, the master regulator of that process. It is also a remarkable redox cofactor, reportedly cycling through thousands of oxidation-reduction reactions before degrading, against roughly four for vitamin C.

Improving the function of existing machinery and increasing the amount of machinery are different interventions with different timescales and different plausibility. Selling them as interchangeable "mitochondrial support" obscures that entirely.

The evidence gap, stated plainly

Our CoQ10 ingredient page carries a Strong badge. Our PQQ page carries Emerging. That is a two-grade gap and it is deliberate.

CoQ10 has been studied in humans for decades, including in cardiovascular populations, in statin users, and in mitochondrial disease. It has a characterised dose-response, a known safety profile and an established clinical context. Whatever you conclude about its usefulness for a healthy person, the compound itself is not in question.

PQQ's biogenesis claim rests substantially on preclinical work. The human trials that exist are small and short, and the long-term safety data is limited — which our own ingredient data says explicitly. That is not a dismissal. It is a statement about where the compound sits: promising, plausible, and not yet demonstrated in humans at the level its marketing implies. The same reasoning we apply to apigenin applies here — an elegant mechanism is a reason to run the trial, not a substitute for having run it.

Ubiquinone versus ubiquinol, and who actually needs which

CoQ10 exists in two interconvertible states: ubiquinone, the oxidised form, and ubiquinol, the reduced form. Ubiquinol is generally the better-absorbed of the two and is what we recommend at 100–200 mg daily, taken in the morning with a fatty meal — CoQ10 is fat-soluble and absorption without dietary fat is poor enough to waste the dose.

Ubiquinol costs more, and healthy younger adults convert ubiquinone efficiently enough that the premium is arguable. The case for ubiquinol strengthens with age and with conditions that impair the conversion. If you are choosing on a budget, ubiquinone taken with a proper meal beats ubiquinol taken on an empty stomach.

One group has a specific reason to look at this: statin users. Statins inhibit HMG-CoA reductase, which sits upstream of both cholesterol and CoQ10 synthesis, and CoQ10 depletion is a common and expected consequence. Whether supplementation resolves statin-associated muscle symptoms is genuinely contested in the literature and we will not pretend otherwise — but the depletion itself is not contested, and it is a reasonable thing to raise with a prescriber.

The warfarin interaction is the one to remember

CoQ10 is structurally similar to vitamin K and may reduce the effectiveness of warfarin. For anyone anticoagulated, this is not a footnote — it is a reason to involve the clinic before starting, and to expect INR monitoring afterwards.

Beyond that, CoQ10 is well tolerated; rare reports of mild insomnia, headache or gastrointestinal upset are the extent of it, and taking it in the morning avoids most of the insomnia complaints. PQQ is likewise well tolerated in the short human data available, with occasional headache and drowsiness reported — but "well tolerated in limited short-term data" is a weaker statement than it sounds, and worth reading as written.

How to read a mitochondrial supplement label

"Mitochondrial support" is an unregulated phrase and the products carrying it vary enormously. Four checks separate the serious from the decorative.

Is the CoQ10 form stated? Ubiquinone and ubiquinol are different materials at different prices, and a label saying only "CoQ10 200 mg" is telling you the less useful half of what you need to know. If it does not say, assume ubiquinone.

Is there enough fat context? CoQ10 is fat-soluble and notoriously poorly absorbed. Products that solubilise it — in an oil base, a softgel, or a formulated delivery system — have a real advantage over a dry powder in a two-piece capsule. This is one of the few cases where the delivery format is not marketing.

Is the PQQ dose in the studied range? Ten to twenty milligrams is what the human work uses. PQQ is expensive per milligram, and underdosing it is an easy way to put an impressive ingredient on a label cheaply. A product listing PQQ without a milligram figure, or at a fraction of that range, is using the name rather than the compound.

What else is in there? Mitochondrial blends frequently include a long tail of ingredients at token doses — resveratrol, alpha-lipoic acid, various berry extracts — which raise the ingredient count and the price without reaching a dose any of them was studied at. The test we apply throughout our stack rankings is whether each named ingredient appears at an amount you could look up in a trial. Most long-tail blends fail it.

A related point worth internalising: a longer ingredient list is a marketing asset and a formulation liability. There is a fixed amount of powder that fits in a capsule, so every additional ingredient reduces the room available for the ones that matter. Two compounds at studied doses beats fourteen at sprinkles, every time.

Do they belong together?

The combination is mechanistically sensible: more mitochondria with adequate electron-transport capacity is a coherent aim, and the two compounds address different halves of it. Many products pair them for exactly this reason, and it is one of the few supplement pairings where the rationale is not retrofitted.

The honest caveat is that pairing them makes it impossible to know which one, if either, is doing anything for you — the same evaluation problem that dogs apigenin in a sleep stack. If you want to find out, run CoQ10 alone for six weeks first. It is the better-evidenced of the two, so if a single compound is going to earn its place, that is the one to test.

Both also sit naturally alongside the compounds in our Longevity Protocol and alongside acetyl-L-carnitine, which handles the fatty-acid transport step that feeds the chain CoQ10 operates in. Between them those three cover substrate delivery, throughput and capacity.

How this compares with the NAD+ route

Mitochondrial supplements split into roughly two camps: the electron-transport group covered here, and the NAD+ precursor group — NMN and NR — covered in our NMN versus NR comparison. They are not substitutes. NAD+ is a coenzyme the chain depends on; CoQ10 is a carrier within it; PQQ proposes to increase how much chain there is.

If you are trying to choose one place to start, the evidence hierarchy is not subtle: CoQ10 has the strongest human record of the group, particularly if you take a statin or are over fifty. PQQ is the speculative addition, and it should be bought as a speculation rather than as a conclusion.

And before adding any of them, one point stands over everything in our longevity science coverage: nothing in this category outperforms sleep, resistance training and not being deficient in the basics. These are additions to that foundation, never replacements for it.

More from The Evidence Files

This piece is part of a ten-part series working through the compounds we hold structured dosing and interaction data for. The companion pieces most relevant here:

• Acetyl-L-carnitine — the substrate-delivery step in the same chain
• Creatine for the brain — the ATP buffer that sits downstream of all of it
• Apigenin — another compound whose mechanism outruns its trials

Disclaimer: This content is for informational purposes only and is not medical advice. Statements about supplements have not been evaluated by the Food and Drug Administration, and nothing here is intended to diagnose, treat, cure, or prevent any disease. If you take prescription medication or have a medical condition, consult a qualified healthcare professional before using any supplement. Contains affiliate links — see our disclosure.